Adaptive resistance to PI3Kα-selective inhibitor CYH33 is mediated by genomic and transcriptomic alterations in ESCC cells

Cell Death & Disease, Published online: 14 January 2021; doi:10.1038/s41419-020-03370-4Adaptive resistance to PI3Kα-selective inhibitor CYH33 is mediated by genomic and transcriptomic alterations in ESCC cells
Source: Cell death and disease - Category: Internal Medicine Authors: Source Type: research
More News: Internal Medicine | Men